Log in

IBP Indo-Bangla Pharmaceuticals Ltd. DSEBD · Bangladesh

Indo-Bangla Pharmaceuticals (IBP) news

Indo-Bangla Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker IBP, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Indo-Bangla Pharmaceuticals news

We have not published a story on Indo-Bangla Pharmaceuticals yet. When there is news, it will appear here.

Questions about Indo-Bangla Pharmaceuticals

What is the ticker symbol of Indo-Bangla Pharmaceuticals?

Indo-Bangla Pharmaceuticals Ltd. trades under the ticker IBP on DSEBD.

Where is Indo-Bangla Pharmaceuticals listed?

Indo-Bangla Pharmaceuticals Ltd. is listed on DSEBD.

Which country or territory is Indo-Bangla Pharmaceuticals listed under?

Our directory records Indo-Bangla Pharmaceuticals Ltd. under Bangladesh.

What does Indo-Bangla Pharmaceuticals do?

Our directory classifies Indo-Bangla Pharmaceuticals Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Indo-Bangla Pharmaceuticals?

The ISIN recorded for Indo-Bangla Pharmaceuticals Ltd. is BD0494IBPL08.

Does aibio.space cover Indo-Bangla Pharmaceuticals?

aibio.space lists Indo-Bangla Pharmaceuticals Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Indo-Bangla Pharmaceuticals?

Companies in our directory listed in the same country and business area as Indo-Bangla Pharmaceuticals: Active Fine Chemicals, Silco Pharmaceuticals, Silva Pharmaceuticals, Libra Infusions, Techno Drugs, Square Pharmaceuticals.

Investor discussion: Indo-Bangla Pharmaceuticals

Members talk about Indo-Bangla Pharmaceuticals (IBP). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Indo-Bangla Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker IBP, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Indo-Bangla Pharmaceuticals Ltd.
Ticker
IBP
Listing
DSEBD
Country or territory
Bangladesh
Business scope
Pharmaceuticals: Major
ISIN
BD0494IBPL08
Last quote in directory
2026-10-19
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.